Myriad Genetics
MYGN
$18.18
Share price
1.11%
Change (1 day)
-14.20%
Change (1 year)
Myriad Genetics (MYGN) - P/B ratio
P/B ratio as of April 2024 : 2.10
According to Myriad Genetics's latest financial reports the company has a price-to-book ratio of 2.10.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Myriad Genetics - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.19 | 65.03% |
| 2022-12-31 | 1.33 | -41.71% |
| 2021-12-31 | 2.28 | 38.88% |
| 2020-12-31 | 1.64 | -12.92% |
| 2019-12-31 | 1.88 | -5.83% |
| 2018-12-31 | 2.00 | -23.12% |
| 2017-12-31 | 2.60 | 67.11% |
| 2016-12-31 | 1.56 | -61.17% |
| 2015-12-31 | 4.01 | 14.26% |
| 2014-12-31 | 3.51 | 52.82% |
| 2013-12-31 | 2.30 | -31.39% |
| 2012-12-31 | 3.35 | 16.32% |
| 2011-12-31 | 2.88 | -21.6% |
| 2010-12-31 | 3.67 | -24.51% |
| 2009-12-31 | 4.86 | -18.01% |
| 2008-12-31 | 5.93 | 0.6% |
| 2007-12-31 | 5.89 | 11.29% |
| 2006-12-31 | 5.29 | 70.22% |
| 2005-12-31 | 3.11 | -30.73% |
| 2004-12-31 | 4.49 | 85.4% |
| 2003-12-31 | 2.42 | 7.76% |
| 2002-12-31 | 2.25 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.80 | 128.77% | 🇺🇸 USA |
 Exact Sciences EXAS | 3.40 | 61.72% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 3.11 | 47.86% | 🇺🇸 USA |
 Biocept
BIOC | 3.94 | 87.51% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 0.9012 | -57.09% | 🇺🇸 USA |